ScienceDex / Researcher record
Terry Roemer
- Prokaryotics, Inc. (no department on record)
- Hackensack University Medical Center (no department on record)
- Johns Hopkins University (no department on record)
From the FY2025 NIH awards this investigator leads as contact PI. The department is the award's.
FY2025 NIH rank #2,175
- Rising Star
- R01 Holder
- Multi-Institutional
- Early Career
- Diverse Portfolio
NIH Funding · FY2025
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,949,510 | 3 | #5,609 |
| 2025 | $3,868,408 | 6 | #2,175 |
| 2026 | $16,558,011 | 5 | #274 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20243 records
- FY2025 · selected6 records
- FY20265 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 12254697Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2025 award records by amount
NIH award records listing Terry Roemer as a PI. Multi-PI records show the full award amount for context.
- 4R44AI165008-02R44Contact PIDevelopment of a mechanistically novel synergistic adjuvant to partner with polymyxin antibiotics$996.5Kaward amount
- 1U19AI189168-01U19Contact PICenter for accelerated development of drug candidates targeting high threat bacterial infections$944.1Kaward amount
- 1U19AI189183-01U19Contact PIAccelerator for the rapid development of countermeasures targeting drug resistant fungal pathogens$778.5Kaward amount
- 5R01AI165740-03R01Contact PIDevelopment of a mechanistically novel Gram-negative antibiotic targeting MsbA-mediated Lipopolysaccharide Biogenesis$679.7Kaward amount
- 1R44AI188848-01A1R44Contact PIDevelopment of an active site inhibitor of Fks1 as a broad spectrum antifungal agent$299.7Kaward amount
- 1R21AI185171-01A1R21Contact PIStructure-based design of antifungal inhibitors targeting the glycosylphosphatidylinositol (GPI) ethanolamine phosphate transferase, Mcd4$170Kaward amount
Award organizations
Organizations that administered FY2025 awards listing Terry Roemer as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardProkaryotics, Inc.
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #5609
- 2025$2M Cumulative Funding
- 2025$5M Cumulative Funding
- 2025Entered Top 25% NationallyRanked #2175
- 2025Multi-Institutional ResearchAwards at 3 institutions
- 2025R01 Grant Holder
- 2026$10M Cumulative Funding
- 2026Entered Top 10% NationallyRanked #274
- 2026Entered Top 5% NationallyRanked #274
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Terry Roemer.
Andrew Nelson
Johns Hopkins University
2
shared awards
Andrew Nelson
Hackensack University Medical Center
2
shared awards
Arturo Casadevall
Johns Hopkins University
2
shared awards
David Alland
Hackensack University Medical Center
2
shared awards
David Alland
Johns Hopkins University
2
shared awards
David S Perlin
Hackensack University Medical Center
2
shared awards
David S Perlin
Johns Hopkins University
2
shared awards
James M Balkovec
Johns Hopkins University
2
shared awards
James M Balkovec
Hackensack University Medical Center
2
shared awards
Richard H. Ebright
Hackensack University Medical Center
2
shared awards